Weight-Loss drug muscle risk under microscope: new study targets seniors
NCT ID NCT07104539
First seen Jan 31, 2026 · Last updated May 03, 2026 · Updated 13 times
Summary
This study looks at whether popular GLP-1 weight-loss drugs (like Wegovy or Zepbound) cause muscle loss or affect balance in adults aged 50 and older. Thirty participants who just started taking these drugs will undergo 14 weeks of strength training. Researchers will measure changes in muscle mass, walking ability, and balance using a special treadmill test. The goal is to understand if these medications increase fall risk in older adults.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE MASS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Virginia Tech
RECRUITINGBlacksburg, Virginia, 24061, United States
Conditions
Explore the condition pages connected to this study.